Comparative study between Amalaki eyedrop and Olopatadine 0.1% in management of Allergic Conjunctivitis.

Randomised controlled trial of Amalaki Eye drop in comparison with Olopatadine 0.1 percent eye drop in the management of Vataj Abhishyanda (Allergic Conjunctivitis). - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075542

Enrollment

100

Registered

2024-10-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient suffering from symptoms of vataj Abhishyanda i.e irritation in eye, Foreign Body Sensation, Hyperemic conjunctiva, Swollen lids, and Watery discharge will be selected irrespective of their sex, education, socio economic status & religion.

Exclusion criteria

Exclusion criteria: 1) Patients with any other ocular pathology like Bacterial conjunctivitis, corneal opacity, corneal ulcer, Malignancy, Immunosuppressive disorder 2) Cases complicated with dacryocystitis

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Amalaki eye drop in reducing inflammation in Vataj Abhishyanda (Simple Allergic Conjunctivitis). Timepoint: 5 days	—

Secondary

Measure	Time frame
To develop evidence-based support for effect of Amalaki Eye drop in Vataj Abhishyanda. Timepoint: 5 days	—

Countries

India

Contacts

Public ContactDr Santosh Prakash Rahinj

Dr D Y Patil College of Ayurved and Research Centre , Pimpri, Pune-18

mayur.shiralkar@dpu.edu.in8600866097

Outcome results